rs3814055

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000466380.6(NR1I2):​c.-1135C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.352 in 152,196 control chromosomes in the GnomAD database, including 9,775 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 9767 hom., cov: 33)
Exomes 𝑓: 0.36 ( 8 hom. )

Consequence

NR1I2
ENST00000466380.6 5_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.03

Publications

132 publications found
Variant links:
Genes affected
NR1I2 (HGNC:7968): (nuclear receptor subfamily 1 group I member 2) This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008]
NR1I2 Gene-Disease associations (from GenCC):
  • pediatric lymphoma
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000466380.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.382 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000466380.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NR1I2
ENST00000466380.6
TSL:1
c.-1135C>T
5_prime_UTR
Exon 1 of 9ENSP00000420297.2O75469-4
ENSG00000285585
ENST00000648112.1
c.*2-26041C>T
intron
N/AENSP00000497876.1

Frequencies

GnomAD3 genomes
AF:
0.352
AC:
53532
AN:
151956
Hom.:
9764
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.287
Gnomad AMI
AF:
0.456
Gnomad AMR
AF:
0.368
Gnomad ASJ
AF:
0.499
Gnomad EAS
AF:
0.222
Gnomad SAS
AF:
0.371
Gnomad FIN
AF:
0.365
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.386
Gnomad OTH
AF:
0.361
GnomAD4 exome
AF:
0.361
AC:
44
AN:
122
Hom.:
8
Cov.:
0
AF XY:
0.400
AC XY:
24
AN XY:
60
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AF:
0.500
AC:
2
AN:
4
Ashkenazi Jewish (ASJ)
AF:
0.700
AC:
7
AN:
10
East Asian (EAS)
AF:
0.313
AC:
5
AN:
16
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.286
AC:
4
AN:
14
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.371
AC:
26
AN:
70
Other (OTH)
AF:
0.00
AC:
0
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.352
AC:
53560
AN:
152074
Hom.:
9767
Cov.:
33
AF XY:
0.350
AC XY:
26040
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.287
AC:
11920
AN:
41510
American (AMR)
AF:
0.367
AC:
5618
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.499
AC:
1731
AN:
3472
East Asian (EAS)
AF:
0.222
AC:
1149
AN:
5172
South Asian (SAS)
AF:
0.371
AC:
1788
AN:
4820
European-Finnish (FIN)
AF:
0.365
AC:
3853
AN:
10548
Middle Eastern (MID)
AF:
0.439
AC:
129
AN:
294
European-Non Finnish (NFE)
AF:
0.386
AC:
26197
AN:
67942
Other (OTH)
AF:
0.359
AC:
759
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1773
3546
5319
7092
8865
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.376
Hom.:
49689
Bravo
AF:
0.348
Asia WGS
AF:
0.272
AC:
946
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
4.6
DANN
Benign
0.72
PhyloP100
-1.0

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3814055;
hg19: chr3-119500035;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.